Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Gotlib

Showing results (171-180 of 210) with videos related to

Pageof 21
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Prithviraj Bose, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 20, 2022
Proposed European Competence Network on Mastocytosis-American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic MastocytosisJason Gotlib, Juliana Schwaab, William Shomali, et al.
Journal of the American Academy of Dermatology|February 14, 2026
Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER studyFrank Siebenhaar, Sigurd Broesby-Olsen, Mariana Castells, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2016
NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017Arnel Pallera, Jessica K Altman, Ellin Berman, et al.
Leukemia|August 30, 2022
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patientsBarbara Mora, Paola Guglielmelli, Andrew Kuykendall, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Haris Ali, et al.
Cancers|December 24, 2021
Comparison of the Transcriptomic Signatures in Pediatric and Adult CMLMinyoung Youn, Stephanie M Smith, Alex Gia Lee, et al.
British Journal of Haematology|September 22, 2025
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR studyCelalettin Ustun, Mei-Jie Zhang, Andrew Peterson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 8, 2021
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)Patrizia Bonadonna, Knut Brockow, Marek Niedoszytko, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2024
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024Jason Gotlib, Aaron T Gerds, Peter Abdelmessieh, et al.
Pageof 21

Showing results (171-180 of 210) with videos related to

Sort By:
Pageof 21
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Prithviraj Bose, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 20, 2022
Proposed European Competence Network on Mastocytosis-American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic MastocytosisJason Gotlib, Juliana Schwaab, William Shomali, et al.
Journal of the American Academy of Dermatology|February 14, 2026
Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER studyFrank Siebenhaar, Sigurd Broesby-Olsen, Mariana Castells, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2016
NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017Arnel Pallera, Jessica K Altman, Ellin Berman, et al.
Leukemia|August 30, 2022
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patientsBarbara Mora, Paola Guglielmelli, Andrew Kuykendall, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Haris Ali, et al.
Cancers|December 24, 2021
Comparison of the Transcriptomic Signatures in Pediatric and Adult CMLMinyoung Youn, Stephanie M Smith, Alex Gia Lee, et al.
British Journal of Haematology|September 22, 2025
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR studyCelalettin Ustun, Mei-Jie Zhang, Andrew Peterson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 8, 2021
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)Patrizia Bonadonna, Knut Brockow, Marek Niedoszytko, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2024
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024Jason Gotlib, Aaron T Gerds, Peter Abdelmessieh, et al.
Pageof 21